Skip to main content
editor@ajptr.com
9409046853
e-ISSN: 2249-3387
American Journal of PharmTech Research

American Journal of PharmTech Research

American Journal of PharmTech Research

AJPTR | Peer-Reviewed, Open Access Pharmaceutical Technology Research Journal

The American Journal of PharmTech Research (AJPTR) is a peer-reviewed, open-access journal publishing original research, review articles, and scholarly work in pharmaceutical sciences and pharmaceutical technology, including drug delivery systems, pharmaceutical formulation, pharmaceutical nanotechnology, pharmaceutical analysis, and biotechnology.

Bimonthly Publication | Est. 2011 | e-ISSN: 2249-3387

📢 Latest Update:  Call for Papers 2026 — AJPTR Now Accepting Manuscripts for September 2026 | Open Access | Fast Review | Deadline: September 15, 2026

📢 Latest Update:  Call for Papers 2026 — AJPTR Now Accepting Manuscripts for September 2026 | Open Access | Fast Review | Deadline: September 15, 2026

Important Journal Details

Title:
American Journal of PharmTech Research
Journal Short Name:
AJPTR
e-ISSN (Online):
2249-3387
Year of Establishment:
2011
Frequency of the Publication:
Bi-Monthly (1 Issue / 2 months)
Publication Format:
Online
Publication URL:
https://ajptr.com
Related Subject:
Drug DevelopmentFormulationPharmaceutical NanotechnologyB...+ View more
Language:
English
Editor-in-Chief:
Dr H J Patel
Editorial Board:
Click Here →
Journal's Email ID:
editor@ajptr.com

Download Forms & Formats

Download Hub

Journal Features

Rigorous Peer Review

All submissions undergo Double-blind review by subject experts, avg. 4 to 5 day turnaround.

Global Reach

Published papers reached an international audience in 195+ countries of researchers, academics, and industry professionals.

Rapid Publication

Efficient review process ensures timely publication of accepted papers without compromising quality. Bi-monthly issues, rolling submissions, fast decision

Open Access

All published papers are freely accessible online, maximizing visibility and impact of your research.

Publication Procedure

1

Prepare Manuscript

Format your paper according to our guidelines

View Guidelines
style="fill: var(--journal-600);"
2

Submit Paper

Upload your manuscript through our system

Submit Now
3

Peer Review

Your paper undergoes expert evaluation

Learn More
4

Publication

Accepted papers are published worldwide

View Publications
View All Issues
Cover image for HERBAL ANTACID CHEWING GUMS: A COMPREHENSIVE REVIEW ON NATURAL THERAPEUTICS, FORMULATION, EVALUATION AND PATENT LANDSCAPE

HERBAL ANTACID CHEWING GUMS: A COMPREHENSIVE REVIEW ON NATURAL THERAPEUTICS, FORMULATION, EVALUATION AND PATENT LANDSCAPE

Smt. Aishwarya Hiremath, Samarth A V, Nithish S, Suhas T G, Sakshi Poojitha J

Herbal antacid chewing gum is becoming popular as one of the simplest and most patient-compliant ways to treat acidity and related stomach issues. Safe and convenient therapy appears to be in demand given the prevalence of illnesses like GERD (gastroesophageal reflux disease), etc. The advantages of using natural herbal remedies in conjunction with chewing gum therapy seem to be a practical approach. Saliva secretion increases the gastric acid's buffering effect during chewing, ensuring a gradual release of the active substances. This review highlights few of the popular used herbal agent used as antacid and gastroprotective and explains the role of herbs in managing acidity. Different strategies for formulating are discussed along with significant materials and preparation techniques. Few significant parameters to be measured are discussed like acid neutralizing capacity, drug release, texture, stability. Available patents, future prospects are briefly discussed. In conclusion, it can be stated that chewing gums for antacids using herbal agents offer a good substitute. KEY WORDS: Herbal antacid chewing gum, gastroprotective activity, acid neutralization, herbal formulations, chewable dosage form.

Cover image for A NOVEL NANOEMULSION FORMULATION OF APREMILAST FOR PSORIASIS

A NOVEL NANOEMULSION FORMULATION OF APREMILAST FOR PSORIASIS

Dr. Ajit Kumar Pandey, Vandana Bhagat

Apremilast, an oral phosphodiesterase-4 (PDE-4) inhibitor, is widely used in the treatment of inflammatory diseases such as psoriasis and psoriasis arthritis. However, its poor water solubility to formulate and evaluate a Nanoemulsion (NE) system for Apremilast to enhance its solubility, stability, and bioavailability. A Nanoemulsion was developed using a high energy emulsification method, with a combination of oil, surfactant, and co-surfactant carefully selected based on solubility studies and construction of pseudo-ternary phase diagrams. Various formulations were prepared and evaluated for droplet size, polydispersity index (PDI), zeta potential, and drug encapsulation efficiency. The optimized formulation exhibited a droplet size of below 600 nm, a low PDI, and a stable zeta potential, confirming its stability. According to this report, the Nanoemulsion based delivery system for Apremilast drug could offer significant clinical advantages, particularly in terms of improved pharmacokinetics and enhanced therapeutics outcomes, paving the way for more effective treatment of inflammatory diseases such as psoriasis and psoriatic arthritis. Further in vivo studies are recommended to confirm the observed benefits and to evaluate long term safety and efficacy.

Cover image for Formulation and Evaluation of Herbal Floating Tablet for The Management of Gastric Ulcer

Formulation and Evaluation of Herbal Floating Tablet for The Management of Gastric Ulcer

Ms. Poonam A. Jadhav, Priyanka Sandip Sabale, Sanika Ajit Salvi

Peptic ulcer is a common gastrointestinal disorder characterized by mucosal damage in the stomach or duodenum due to an imbalance between aggressive factors such as gastric acid and protective mucosal defense. Conventional anti-ulcer drugs, although effective, are often associated with high cost and adverse effects. Therefore, the present study aimed to develop and evaluate polyherbal floating tablets as a safer and more effective alternative for gastric ulcer management. The formulation incorporated extracts of Annona squamosa with sodium bicarbonate as a gas-generating agent to enhance buoyancy and prolong gastric retention. Tablets were prepared using the direct compression method by blending plant extracts with suitable polymers and excipients. The prepared formulations were evaluated for physicochemical properties and showed satisfactory results. The floating drug delivery system demonstrated potential for prolonged gastric residence time, which may improve therapeutic efficacy and patient compliance.

Publication Procedure

Learn about our 4-step publication process

Author Guidelines

Review requirements before submitting

Submit Article

Ready to submit your research?

2,910
Published Articles
1,523
Active Researchers
195
Countries
4.2
Impact Factor
Whatsapp